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Abstract
Objectives: To summarize 1) the definitions and epidemiological features of stroke in children; 2) the main 
risk factors that can lead to stroke in pediatrics and neonatology; 3) the main pathophysiological features involved 
in the genesis of brain injury in stroke; 4) the clinical manifestations and imaging diagnosis; and 5) the latest 
recommendations concerning the support measures, treatment, and prophylaxis of stroke in children.
Sources: A review of the literature published in PubMed, EMBASE, and SciELO databases using the search 
terms stroke, pediatrics, and neonatology was performed, including relevant references from the chosen texts.
Summary of the findings: Stroke in children are rare conditions, with incidence rates among two and 
eight per 100,000 children up to 14 years, and most cases show an underlying disease such as heart diseases, 
prothrombotic conditions, sickle-cell disease, and vascular malformations. There are no specific guidelines currently 
in place for the treatment of stroke in children, although central elements include support treatment, monitoring, 
and anticoagulation as secondary prevention in certain cases. Prognosis depends on the extent of brain damage 
and the underlying disease but recurrence rates are high in most cases.
Conclusions: Early diagnosis of stroke in children is very important and pediatricians should be aware of the 
lack of specificity of the symptoms to avoid late sequelae and improve life quality.
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Introduction
Strokes in children are rare but increasingly important 
conditions due to the severity of their complications and 
diverse diagnostic differentials. Diagnosis requires a high 
level of clinical suspicion since the initial signs and symptoms 
manifested may lack specificity, with clinical presentations 
of other neurological diseases or non-central nervous 
system related conditions. Studies have shown a time lag 
between onset of clinical manifestations and diagnosis of 
between 35 and 72 h.1 A retrospective analysis published 
by McGlennan et al.2 studied 50 children with acute stroke 
or transient ischemic attack. In 24 h after the onset of 
symptoms, 64% of the patients did not have a consult with 
a pediatric neurologist and 39% of them did not have an 
initial neuroimaging in the same time. The diagnosis was 
performed in more than 24 h in most children in this study. 
Adult stroke has different risk factors, clinical manifestations 
and outcomes comparing to pediatric stroke.3 The rationale 
behind this update is to assess the main pathophysiological 
mechanisms that lead to stroke in children and review the 
latest recommendations on management of stroke.
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Definitions
A stroke is characterized by clinical and neurological 
manifestations of stroke, together with radiological 
evidence of ischemia or infarct in a given arterial territory 
(acute ischemic stroke, AIS), or hemorrhage (hemorrhagic 
stroke, HS).4 Symptoms of stroke which last less than 24 
h are called transient ischemic attacks.5 Strokes can be 
divided into neonatal strokes, which encompass pre-natal, 
perinatal (between 28 weeks’ gestation and 7 days of life), 
and neonatal (first month of life) periods, and into non-
neonatal or childhood strokes (beyond 1 month of age). 
Differentiating between pre-natal and perinatal conditions 
can be difficult, so some authors group these two periods 
into a single category.
Epidemiological features
The incidence of stroke in children ranges from two to 
eight per 100,000 up to 14 years per year, comprising similar 
proportions of AIS and HS.6 Excluding the first year, this 
rate falls by 50%. American data show that 3,000 children 
are affected per year. Perinatal and neonatal strokes give an 
incidence of 10 to 18 in 100,000 live births, while studies have 
reported rates of up to 63/100,000.7 In view of its different 
clinical manifestations, its diverse causes and low suspicion 
for stroke in pediatrics, these data may underestimate the 
true incidence of stroke in this group. Stroke recurrence 
in children can reach 20%, and in the presence of multiple 
risk factors recurrence can be as high as 42%.8
A demographic survey conducted between 1979 and 1998 
showed a significant decrease (58%) in death from stroke 
in children. This survey revealed higher risk of mortality in 
black children (after exclusion of sickle-cell cases), with a 
relative risk of 1.75, and in male children (relative risk of 
1.21 excluding AIS).9
One of the first epidemiological findings from the 
International Pediatric Stroke Study found a male 
predominance in childhood AIS in all age groups studied.10 
During the period of 4 years, 1,187 children with AIS or 
cerebral sinovenous thrombosis were studied in 30 centers 
located in 10 countries including all continents. In the 
neonatal period, 61% of the patients with AIS were boys 
(p = 0.011); in childhood, 59% were boys (p = 0.002); 
and in all ages, 60% were boys (p < 0.0001), confirming a 
male predominance as described in former studies.
Etiology and risk factors
The risk factors for pediatric stroke are manifold and 
differ from those in adult stroke (including hypertension, 
atherosclerosis, smoking and obesity). The majority of 
AIS have underlying diseases such as sickle-cell and 
congenital or acquired cardiac diseases, whereas causes 
of HS include vascular malformations and trauma. Almost 
30% of pediatric strokes and most newborn strokes have 
no evident risk factors.11 The major causes of stroke in 
children are as follows:
- Cardiac disease – congenital (aortic stenosis, defects 
in atrial or ventricular septum, aorta coarctation, 
patent ductus arteriosus) or acquired (arrhythmias, 
endocarditis, myocarditis, rheumatic disease, atrial 
myxoma);
- Hematological disease – sickle-cell disease (SCD), leukemia 
or lymphomas, polycytemia, thrombocytosis;
- Coagulopathies – deficiencies in protein S or C, vitamin 
K, antithrombin III, factors V Leiden, VII or XIII; lupic 
anticoagulant, oral birth control pills, pregnancy;
- Vasculitis – post-infectious (meningitis, varicella, HIV, 
mycoplasma), immunomediated (Henoch-Schönlein 
purpura, systemic lupus erythematosus), post-radiation 
or chemotherapy, adverse reactions to medications;
- Vascular anomalies – aneurysms, arteriovenous 
malformations, Moyamoya disease, arterial 
dissection;
- Venous infarcts – cerebral sinovenous thrombosis, 
shock;
- Metabolic disorders – mitochondrial encephalomyopathy, 
lactic acidosis and stroke-like episodes (MELAS 
syndrome), homocystinuria and mutation in the 
methyltetrahydrofolate reductase (MTHFR) gene, 
mitochondrial diseases, lipid anomalies;
- Vasospasm – migraine, drug use (cocaine, glue);
- Trauma and other causes – subdural and epidural 
hematomas, subarachnoid hemorrhage, spontaneous 
or traumatic dissection, dehydration, brain tumor.
Ganesan et al.12 published a study showing risk factors 
for recurrence of AIS in children. Their study found a 
recurrence rate of 37% within 1 to 11.5 years of the first 
stroke. Moyamoya disease and low birth weight were 
independent risk factors for recurrence in this group. 
Prothrombotic states were also risk factors. Other factors 
associated with radiological recurrence included previous 
transient ischemic attack, bilateral infarct, underlying 
diseases and leukocytosis.
Perinatal ischemic stroke
Defined as a group of heterogeneous conditions with 
focal disruption of cerebral blood flow secondary to arterial 
or cerebral venous thrombosis or embolization, between 20 
weeks of pregnancy through the 28th postnatal day, and 
confirmed by neuroimaging or neuropathological studies.13 
Clinical manifestations in this group are even less specific,14 
the most common being seizures, apnea, and decreased 
level of consciousness. In the pediatric population, 25% of 
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AIS and 43% of sinovenous thrombosis events occur during 
the perinatal age.15
The main risk factors for perinatal stroke include 
maternal, placental, hematologic, and cardiac. Primiparity, 
infertility, preeclampsia and prolonged rupture of membranes 
are included as risk factors. Early in the neonatal age, 
manifestations of prothrombotic conditions may appear in 
20 to 68% of neonates with AIS. Embolisms can be found 
in neonates with heart diseases.
In preterm newborns, intracranial hemorrhage, mainly 
in very preterm infants (less than 28 weeks of pregnancy), 
is the most common event observed. As the brain blood 
flow in the newborn is directly correlated to systemic 
blood pressure, hypotension can cause a decrease in 
brain blood flow and consequently lesion of the germinal 
matrix. The latter can be related to other situations such 
as rapidly saline infusion, pneumothorax or interstitial 
emphysema. Intracranial hemorrhage may occur in about 
25% of newborns with birth weight between 501 and 
750 g and about 12% with birth weight between 751 
and 1,000 g.16
Pregnancy itself raises risk of thrombotic events, largely 
due to low levels of activated protein S and C.17 Intracranial 
hemorrhages in neonates may present no symptoms, even 
in moderate to severe hemorrhages because of the lack of 
specificity of the symptoms at this age.18
In spite of being a widely accepted measure for 
newborns, lack of administration of vitamin K may cause 
late hemorrhagic disease in infants aged between 2 and 
12 weeks, with severe neurologic impairment. It is an alert 
and pediatricians should be aware of the recommended 
prophylaxis for the hemorrhagic disease of the newborn 
with 1 mg of intramuscular vitamin K.19
Strokes account for approximately 10% of the seizures 
during the neonatal age, and most often manifest as focal 
motor crises involving one extremity. These events are 
strongly associated with cognitive and/or motor sequelae 
during childhood, with some degree of compromise found 
in 28 to 58% of stroke cases. A retrospective analysis 
conducted by Golomb et al. which assessed follow-up 
in children diagnosed with perinatal stroke revealed 
that approximately 60% of these cases had developed 
epilepsy at 6 months of age. One third of these children 
resolved without the need for anticonvulsant therapy.20 
Ohlweiler et al. found significant impairment in neurological 
development in neonates with HS analyzing muscle 
tone, reflexes, strength, and head control at 6 months 
of corrected age.21
In newborn infants with HS, care should be taken 
to maintain platelets at normal levels while replacing 
coagulation factors and vitamin K in specific cases when 
necessary. Hydrocephalus is common after hemorrhagic 
events and must be managed using ventricular drainage if 
persistent or high volume. In this age group, there are no 
recommendations for use of anticoagulants or thrombolysis 
in ischemic events due to lack of controlled studies.
Stroke and cardiac diseases
Studies have shown a two- to three-fold higher 
prevalence of anatomic cardiac anomalies in stroke cases 
compared to the general population.22 Overall, heart disease 
may account for up to 1/3 of all AIS in children. Among 
congenital diseases, the cyanogenic ones with right-to-
left shunts have the highest complication rates, including 
hypoxemia, polycytemia or cyanosis, and may evolve with 
cerebral ischemia in up to 4% of cases.
During the preoperative period, children with acute 
congenital diseases, hemodynamically stable or otherwise, 
are at high risk of compromised blood pressure and brain 
hypoperfusion23 due to reduced cerebral perfusion resulting 
from low cardiac index, arrhythmias or patent ductus 
arteriosus.
However, the highest risk occurs during the perioperative 
period, especially with extracorporeal membrane oxygenation 
(ECMO). Some degree of neurological dysfunction is observed 
in 25 to 45% of children undergoing ECMO,24 stemming 
from three main factors: systemic inflammatory response 
syndrome, micro and macroemboli, and insufficient cerebral 
blood flow to supply the metabolic needs, such as during 
episodes of hypertension or cardiorespiratory arrest.25 The 
incidence of confirmed AIS in this situation ranges from 1 
to 15%. The main conditions that cause brain injury are 
the systemic inflammation, microvasculopathy causing 
decreased cerebral blood flow, platelet aggregation through 
neutrophil activation and direct injury by oxygen free radicals 
through endothelial activation.
Chow et al.26 assessed risk factors associated with AIS 
occurrence post-ECMO, and found statistically significant 
correlations between patient age at time of surgery, total 
time on ECMO, and shorter preoperative activated partial 
thromboplastin time.
Other risk factors include marked hypothermia during 
ECMO which, despite its neuroprotective effect and reduced 
brain metabolic rate, has a series of deleterious effects; 
limited capacity to autoregulate cerebral blood flow during 
the surgical procedure due to fixed cardiac index, and finally 
constant shifts in blood pH during hypothermia which lead 
to alkalemia, with lower oxygen availability for tissues.
According to Miller et al.,27 mild neuropsychomotor 
developmental delays to severe brain injury are observed 
in 23 to 60% of children.
Another factor for AIS in cardiac disease is bacterial 
endocarditis with septic embolisms. The incidence is not 
known in children but reports in adults have shown a 40% 
incidence of associated neurologic events. Studies have 
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described good prognosis in this high-risk group, with a 
lower probability of motor sequelae following treatment 
for endocarditis.28
Stroke and sickle-cell disease
SCD is one of the leading risk factors for AIS, with 
incidence ranging according to age. The incidence is 0.13% 
in infants younger than 2 years, rising to 1% of cases into 
2-5 years and is 0.79% within 6-9 years. AIS incidence in 
children with SCD may be up to 280 times higher than in 
the pediatric population.29 Considering findings of cerebral 
ischemia on magnetic nuclear resonance studies (MR), 
lesions are found in up to 22% of infant patients.30,31
Risk factors include previous transient ischemic events, 
high blood flow speed on transcranial Doppler, arterial 
hypertension, history of acute thoracic syndrome, low levels 
of hemoglobin, and high leukocyte count, with the latter 
being relevant in cases of HS in children with SCD.
Although vaso-occlusion of the microcirculation 
represents an important cause of morbidity in SCD, 
cerebrovascular disease manifests as vasculopathy of great 
vessels distal to the internal carotid artery, and in proximal 
sections of middle and anterior cerebral arteries. In the 
early 1980s, Gerald et al.32 demonstrated that the lesions 
outlined above affected up to 80% of patients to some extent. 
These findings are corroborated by MR imaging that shows 
high percentages of distal occlusions of great vessels. The 
combination of arterial dilation and weak elastic support 
raises chances for HS.33,34
Major infarcts in the territory of the middle cerebral 
artery secondary to carotid lesions are also a common 
finding. Smaller lesions are also found involving the basal 
ganglia and white matter.
Over a 4-year period, two studies35,36 found high rates 
of stroke recurrence in children with SCD of nearly 30%.
Initial therapeutic measures for pediatric stroke are 
similar to those adopted in children with SCD, with special 
attention to correction of dehydration, hypoxemia and 
hypotension. Blood transfusions are indicated in acute 
cases of stroke to reduce levels of hemoglobin S to less 
than 30% while maintaining hemoglobin between 10 and 
12.5 g/dL.37 In addition, the child must follow a regular 
transfusion program to reduce AIS secondary to SCD, with 
care concerning potential iron poisoning. Annual transcranial 
Doppler has also been recommended in children aged 
between 2 and 16 years (in cases of normal exams), with 
more frequent exams in the event of altered findings of 
arterial blood flow greater than 200 cm/s. A prevention 
rate of 90% in the occurrence of stroke has been described 
in asymptomatic children with high blood flows on Doppler 
exams and undergoing regular blood transfusion programs.38 
Management without significant supporting evidence may 
be employed in refractory and/or recurrent cases including 
use of hydroxyurea (particularly in children not eligible 
for multiple transfusions), bone marrow transplant and 
revascularization surgery, mainly in patients with multiple 
lesions.
Stroke and Moyamoya disease
Moyamoya (a Japanese word for “puff of smoke” 
referring to the appearance of arterial collateral branches on 
angiography) disease is characterized by chronic, progressive 
stenosis of the intracranial distal portion of the internal 
carotid artery and less commonly by stenosis of the proximal 
portions of anterior, middle, basilar or posterior cerebral 
arteries. The disease is responsible for up to 6% of strokes 
in Western countries, but has greater incidence in oriental 
children affecting three in every 100,000 children per year, 
with a female-male ratio about 1:8. Two peaks of age at the 
onset of the symptoms are suggested – the first at 5 years 
of age and a lower peak at about 40 years old.39
Diagnosis requires stenosis involving the distal part of 
the bifurcation of the internal carotid artery and proximal 
portions of the middle and anterior cerebral arteries, the 
finding of arterial collateral branches and the characteristic of 
bilateral alterations. This definition remains controversial and 
in 2002 Sebire et al.40 proposed that a finding of unilateral 
stenosis associated with typical collateral branches should 
also define the disease. The name Moyamoya disease is also 
given to the finding of these radiological features without 
presence of risk factors, while Moyamoya syndrome denotes 
the association of the features described in conjunction 
with factors such as SCD, neurofibromatosis or infections. 
Concerning Moyamoya syndrome, Dobson et al.41 carried 
out a retrospective analysis of 44 children with SCD, and 
the chances of recurrent AIS in those with Moyamoya 
syndrome over the long term was almost twice as high as 
in the group without these radiological features. From a 
histological standpoint, proliferation of the intima layer of 
arteries, fibrosis, and loss of elasticity lead to progressive 
arterial luminal obstruction.42
Junqueira et al.43 carried out a meta-analysis of patients 
with Down syndrome and Moyamoya disease. It was possible 
to conclude that mean age of onset of the symptoms was 2 
to 7 years old, hemiparesis was the most frequent symptom 
in almost 78% of the patients and most of them presented 
with AIS (about 76%).
Little is known about the pathogenesis of the disease 
but there is evidence, from the fact that 7 to 12% of first-
degree oriental relatives harbor the disease, that genetic 
factors play an important role.
Children with Moyamoya disease can benefit from 
surgical revascularization, particularly those with progressive 
neurological symptoms or evidence of inadequate blood 
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flow and/or collateral circulation and in whom surgery is 
not contraindicated. Use of anticoagulants is not routinely 
recommended due to risk of hemorrhagic events.
Approximately 2/3 of the patients with the disease, 
when untreated, present recurrent AIS. Children can show 
some atypical symptoms such as syncope, paraparesis 
or involuntary movements, characteristically induced 
by hyperventilation. About 25% of the children with the 
disease have complaints of headache, even 1 year after 
revascularization surgery. Bleeding is a symptom more 
common in adults due to the rupture of dilated vessels 
or aneurysms, and may be present in about half of adult 
patients. Prognosis in this disease is related to the speed 
and extent of vascular occlusion, patterns of collateral 
circulation, age at onset of symptoms, degree of neurological 
deficit and size of ischemic brain area on imaging studies. 
Pediatric patients rarely develop AIS after surgery.
Arteriopathy
It is estimated that about 60% of previous healthy 
children have degrees of stenosis of some cerebral arteries 
when diagnosed with AIS. Excluding some known causes of 
arteriopathy such as arterial dissection or Moyamoya disease, 
many have a focal stenosis without known causes. These 
children are now diagnosed with focal cerebral arteriopathy 
of childhood (FCA), as defined by the International Pediatric 
Stroke Study. Amlie-Lefond et al.44 found that 25% of 
children with AIS had FCA with predictors for this disease, 
such as age between 5 to 9 years, recent respiratory 
infections or SCD.
Stroke and prothrombotic conditions
Prothrombotic disease may be present in up to 50% 
of AIS. The main associated conditions are protein C 
or S, antithrombin III and plasminogen deficiencies, as 
well as factor V Leiden mutations, polymorphisms of 
methylenetetrahydrofolate dehydrogenase enzyme (major 
cause of homocystinuria), homocysteinemia and high levels 
of lipoprotein A. Children who are heterozygote for factor V 
Leiden mutation have a seven-fold higher risk of developing 
ischemic events.45,46
A systematic review47 published in 2002 shows that 
these laboratorial changes are present in a greater number 
of children with stroke than those without the disease, 
thereby justifying screening for thrombophilia in all children 
with first AIS.
Hemorrhagic stroke
It encompasses both spontaneous intraparenchymatous 
hemorrhage and non-traumatic subarachnoid hemorrhage.48 
Retrospective analyses have identified the leading causes 
as presence of arteriovenous malformations, hematologic 
diseases (evolving with thrombocytopenia; hemophilia 
and other coagulopathies), brain tumors, cavernous 
hemangiomas, vasculopathy, and cerebral and systemic 
infections. With regard to intraparenchymatous hemorrhage, 
arteriovenous malformations can account for up to half of 
the cases observed. The incidence of HS in children is about 
1.1 per 100,000 children, being almost 80% of cerebral 
hemorrhage and 20% of subarachnoid hemorrhage. Jordan 
et al.49 verified a cohort of 2.3 million children in a mean 
time of 3.5 years and found 116 cases of spontaneous HS. 
Thirteen per cent of these children had cerebral aneurysms 
and considering only subarachnoid hemorrhage almost 57% 
of the children affected had cerebral aneurysms, concluding 
that these malformations may account in large number 
in pediatric acute HS patients. In hematologic disorders, 
patients with immune thrombocytopenic purpura carry a 0.1 
to 1% risk of developing a hemorrhagic event, this risk being 
directly proportionate to platelet count, as demonstrated 
by Butros et al.50 in 2003. Approximately 71% of children 
described in this retrospective analysis had platelet counts 
less than 10,000/mm.
In 2003, Meyer-Heim et al.51 reported the risk factors for 
HS including age (less than 3 years), score less than seven 
on the Glasgow coma scale, hemorrhage in the infratentorial 
region and underlying hemorrhagic disease.
In cases of HS, consultation with a neurosurgeon allied 
with imaging investigations using magnetic resonance 
angiography or conventional angiography are indispensible in 
achieving surgical management. Disturbances in coagulation 
and platelets should be readily treated. No sole therapeutic 
action used in isolation is efficacious in treating this patient 
group. Use of corticosteroids is not recommended based 
on clinical trials with adult patients with intraparenchymal 
hemorrhage; in addition, hyperglycemia may occur as a 
common side effect and is a marker of bad prognosis in 
patient outcome.
Advances in neurosurgical techniques and early diagnosis 
using imaging have substantially reduced the morbidity and 
mortality associated with pediatric HS. Studies have shown 
mortality to be high and variable, reaching rates of up to 
54%, while significant neurological sequelae are seen in 
approximately 42% of child survivors.
Other causes of stroke in children
Vasculitis in children mostly arises from infectious 
events and is hard to diagnose due to the low specificity 
of the diagnostic methods available. This diagnosis should 
be suspected in recurrent events or in those associated 
with fever, multifocal events, associated skins lesions, 
glomerulopathies or high values in inflammatory tests. 
Infections such as tuberculous meningitis, post-varicella 
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encephalopathy, aspergillosis, fungal infections or by other 
virus such as HIV and Coxsackie may also be involved. 
Autoimmune vasculitis, as seen in children with systemic 
lupus erythematosus, may cause ischemic lesions through 
several mechanisms such as release of emboli due to 
endocarditis, presence of anti-phospholipid antibodies, 
and vasculopathy which is commonly associated with 
these pictures.
In children with varicella, the first year post-infection 
represents the high risk window for stroke occurrence. 
Inflammatory vasculopathy, probably following migration 
of the virus through the trigeminal nerve and cervical 
vasculature, is the mechanism associated with varicella.52 
A large retrospective cohort study published by Donahue 
et al.53 was performed to identify the magnitude of new 
stroke cases after varicella vaccination. Almost 1,250,000 
children were vaccinated and 203 new AIS diagnosis were 
made in the first year after vaccination. None of these 
cases occurred in the first 30 days after vaccination and 
multivariate analysis showed no association between 
encephalitis and varicella vaccination. Most of the cases 
had well known risk factors, such as cardiac diseases, 
vascular conditions and SCD.
Critically ill children were studied by Jordan et al.54 In 
this retrospective analysis, 93% of the patients admitted 
in the pediatric intensive care unit had at least one risk 
factor for AIS. In addition, critically ill children with stroke 
had 60 times more chances to die than non-critically ill 
children.
Sinovenous thrombosis of dura mater presents as 
a frequent manifestation of stroke during the neonatal 
age, usually with seizures and lethargy. Disjunctions and 
overlapping of cranial sutures during birth may affect 
cerebral sinus structures, thereby raising the risk of 
stroke. The majority of thromboses occur in the superior 
sagittal sinus with or without associated bilateral sinus 
thrombosis.55 The finding of perinatal asphyxia is also 
commonly concomitant with sinovenous thrombosis, and 
can represent a risk factor for this thrombosis. Coagulation 
disorders are found in up to 20% of newborn infants with 
sinovenous thrombosis.56,57
Patients diagnosed with migraine with aura may be at 
higher risk of AIS, particularly in early adolescence and in 
females using birth control pills. Other situations, such as 
hypertension, dyslipidemia, and diabetes mellitus in children, 
do not carry proven higher risk for stroke.58
Pathophysiological aspects
Cerebral lesions stemming from ischemic or hemorrhagic 
injury are the product of highly complex mechanisms. 
Since brain tissue has a high metabolic requirement for 
oxygen and glucose, any interruption in circulation in the 
areas affected by vascular occlusion leads to depletion of 
metabolic substrates in a matter of minutes, a situation 
exacerbated by subsequent build up of toxic metabolites, 
energy deficits, and damage to affected cells.
Based on a review conducted in 2004, Mergenthaler et 
al.59 compiled a list of the main features involved in the 
genesis of brain injury. The most important is the penumbra 
zone, the area that surrounds the infarcted area and is 
affected by cell apoptosis and proinflammatory cytokines 
representing 50% of brain volume that goes on to infarct. 
Other aspects include cellular toxicity due to excitotoxic 
amino acids and oxygen free radicals leading to osmotic 
lysis of the neurons, tissue acidosis secondary to anaerobic 
metabolism causing neuronal malfunctioning, breakdown 
of blood-brain barrier induced by metalloproteinases and 
finally immunosuppression causing reduced lymphocytes 
and synthesis of interferon-gamma due to activation of 
the sympathetic autonomous nervous system.
Clinical findings
The clinical manifestations of pediatric stroke are diverse 
and often non-specific. Children who present at least one 
of the following clinical characteristics should undergo 
compulsory screening for stroke: acute onset of focal 
neurological deficit of any duration; unexplained change 
in level of consciousness, particularly when associated 
with headache; seizures during the neonatal period, and 
in the post-operative period in children undergoing cardiac 
surgery.60
Seizures are the most common finding during the 
neonatal age and their presence early in diagnosis appears 
to predispose the child to later epilepsy in 8 to 12% of such 
cases.61 In fact, clinical changes, such as hemiparesis, are 
present in less than 25% of neonates with stroke.62
The finding of fontanel depression associated or otherwise 
with pulsatility along with head or cervical venous dilation 
should alert to the possibility of sinovenous thrombosis. 
Late appearance of hemiparesis is a common indicator of 
stroke occurrence in the neonatal period, generally occurring 
between 4 and 8 months of life.63
As age increases, symptomatology tends to more 
closely resemble that of adults. The most commonly 
described symptoms include hemiparesis, decreased level of 
consciousness and cranial nerve lesions. Case series involving 
children older than 1 month show a rate of hemiparesis 
ranging from 85 to 100%.64,65 Other symptoms include 
hemiplegia, monoparesis, dysphasia, headache, dizziness, 
and visual disturbances.
A review conducted in 2007 by Zimmer et al.66 found 
similar proportions of children with seizures or focal deficits 
(45% per group) in infants younger than 1 year of age. 
In older children, however, focal deficits were seven times 
more frequent than seizures. A recent review performed by 
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Chadehumbe et al.67 showed that 58% of children with stroke 
presented seizures within 24 h of the onset of symptoms, 
with no differences found in the rate of seizures according 
to the subtype of the stroke.
Metabolic diseases such as MELAS syndrome are 
characterized by strokes with complete resolution of the 
neurologic symptoms, and events persisting after some 
years include sequelae, mainly visual.68
Diagnostic imaging methods
Diagnosing stroke in children can present technical 
challenges in ascertaining the degree and site of brain 
damage. Computed tomography (CT) of the brain is deemed 
by most authors the most suitable imaging method by virtue 
of its swiftness, practicality and availability, being able to 
clearly reveal hemorrhagic events and differentiate them 
from ischemic events. In addition, CT is less dependent on the 
patient’s clinical stability, a factor which often contraindicates 
use of MR in initial stages of the disease.
Cranial ultrasound is useful in the neonatal period for 
assessing intraventricular and germinal matrix hemorrhage. 
This exam can also detect abnormalities in cerebral blood 
flow in children suspected of presenting extracranial arterial 
dissection. Gauzzi et al.69 studied the use of the posterior 
fontanel in cranial ultrasound in intracranial hemorrhage in 
newborns. Usually, the anterior fontanel is most used but 
can miss occipital strokes and lesions in the occipital zone 
of the lateral ventricles. In this study almost 30% of mild 
hemorrhages were only diagnosed with the posterior fontanel 
ultrasound and other 30% of hemorrhages suspected by 
the anterior fontanel ultrasound were later confirmed with 
the posterior fontanel.
In children with SCD, use of transcranial Doppler provides 
valuable information on blood flow peak speed in terminal 
portions of the internal carotid artery or proximal portions 
of the middle cerebral artery, revealing higher risk of stroke 
at velocities exceeding 200 cm/s.70 However, studies have 
shown that lower speeds of around 128 cm/s also point to 
higher risk and the need to perform more in-depth imaging 
exams in such patients.71
A retrospective study by Steen et al.72 found high rates 
of radiological changes in children with SCD. Radiological 
evidence of cerebral infarct was found in 35% of children 
studied, none of whom had previously been diagnosed with 
stroke. Moreover, occurrence of vascular lesions in children 
with hemoglobin SC patterns is 35% lower than in those 
with hemoglobin SS.
Magnetic resonance angiography is considered the 
gold standard for diagnosing not only brain lesions but 
also possible vascular obstruction and/or lesions which 
triggered the ischemic event. When performed early, this 
exam can detect the beginnings of cerebral infarcts before 
tomographic studies73 and should always be indicated 
if confirmation of AIS has previously been made by any 
other imaging method. Cerebral digital angiography should 
always be considered when negative or conflicting findings 
are found on MR or when no radiological or laboratorial 
evidence is found for the cause of the stroke. The exam is 
also indicated in children with Moyamoya disease who are 
scheduled for revascularization surgery.74 As described by 
Matta et al.75 in retrospective case series, almost 83% of 
children with AIS had obstruction of the middle cerebral 
artery, confirmed by other studies as the most commonly 
involved artery in childhood stroke.
Imaging exams can help reveal the etiology of the 
stroke based on the brain infarct pattern. Findings of 
multiple infarcts in different areas of arterial distribution 
are suggestive of thromboembolytic events, while occipital 
and parietal infarcts with areas of intersection between 
venous territories are common in MELAS syndrome. Finally, 
ischemic distribution between the irrigation territories of 
different cerebral arteries (frontier zones) is common in 
hypotensive events, whereas a pattern of small multifocal 
lesions, mainly in the transition between white and gray 
matter, suggests vasculitis.76
Conventional angiography is superior to other vascular 
imaging approaches such as tomographic angiography or 
resonance angiography for diseases such as vasculitis, 
intracerebral arterial dissections and aneurysms. It is 
important to be aware of the main risks inherent to 
angiography, which include use of iodine contrast with its 
nephrotoxicity and hypersensitivity risks, besides the need 
for arterial puncture with risks of vascular lesion, bleeding, 
and thromboembolism.
Other supplementary exams
An echocardiogram may be helpful to diagnose patent 
foramen ovale; this abnormality can be up to four times 
greater in children with stroke with undetermined etiology 
than in the general population.77
Other causes of acute neurological deficit are included in 
the differential diagnosis of stroke such as seizures, trauma, 
migraine, ventricular obstruction in cases of hydrocephalus, 
brain abscess, metabolic diseases, reaction to drugs, 
meningitis, syncope and drug poisoning.
Treatment
No standard approach currently exists that pools evidence 
based on double-blind or randomized studies, or indicates 
specific recommendations for treating stroke cases in the 
pediatric population.78
The main initial approach is aimed at stabilizing the child 
from the time of admission to the emergency room up to 
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Exam Comments
Cardiac disease assessment: ECG, echocardiogram, Assessing source of embolisms, arrhythmias, and structural
and thoracic radiography abnormalities; lack specificity in the absence of clinical findings 
 of cardiac disease
Cell blood count Non-specific findings for SCD, anemia, thrombocytopenia and 
 infectious diseases
Coagulation tests Assessment of congenital or acquired coagulation 
 (hepatic disease, anticoagulation monitoring)
Antinuclear factor Initial triage to screen for systemic lupus erythematosus
Hemoglobin electrophoresis SCD diagnosis
Lumbar puncture Detection of meningitis and/or encephalitis in children with 
 no clinical or radiologic signs of intracranial hypertension
Lipid profile Assessment of additional risk factors
Hypercoagulability screening Determines levels of Protein C and S, antithrombin III, lupic anticoagulant, 
 anticardiolipin, urinary homocysteine
Arterial lactate and pyruvate Commonly high in MELAS disease 
HIV test Known cause of stroke
Toxicologic screening In high-risk children
Electrolytes, renal function, arterial blood gases  Clinical monitoring
and other tests
Table 1 - Supplementary exams for diagnosing stroke in children
ECG = electrocardiogram; HIV = human immunodeficiency virus; MELAS = mithochondrial encephalomyopathy, lactic acidosis and stroke-like episodes; SCD = sickle-
cell disease.
treatment in intensive care. In contrast to adults, stroke 
in children seldom manifests as severe and acute systemic 
pictures requiring immediate resuscitation measures. 
However, ensuring permeability of the airways, supplying 
oxygenation with sufficient ventilation for hypoxemic children 
and providing adequate circulation are fundamental initial 
steps.
Metabolic, hydric and body temperature controls are 
of paramount importance. As described in Table 1, it is 
important to readily obtain blood samples in the emergency 
room for blood count, prothrombin and thrombin times and 
electrolytes – these disturbances may be early corrected. 
Since no pediatric studies attest the safety and efficacy of 
hypothermia as a clinical measure for reducing cerebral 
metabolic rate, its routine use cannot currently be indicated. 
Glycemic control in critically ill children also lacks specific 
protocols or controlled studies. Nonetheless, a large body 
of recent evidence points to the fact that hyperglycemia in 
critical children significantly raises morbidity and mortality 
in such patients.79 Dehydration and anemia are independent 
risk factors for occurrence of ischemic events, particularly 
thrombotic events during the neonatal period, and should 
thus be managed separately in all cases.
Body temperature control has a huge importance in 
patients with stroke. There are some explanations for the 
impact of fever in worsening brain injury after AIS: 1) 
increased levels of excitatory amino acids, free radicals 
and lactate; 2) breakdown of the blood-brain barrier; 
and 3) impairment in enzymatic functioning and reduced 
cytoskeletal stability. Greer et al.80 carried out a meta-
analysis to find the effects of fever in acute stroke. Fever 
contributed with poor prognosis in stroke in almost all 39 
studies, with an odds ratio of 1.5 for mortality, 1.3 for 
severe neurological deficit, 2.8 for higher intensive care 
unit length-of-stay and 3.2 for longer hospital stay.
Anticoagulant and antiplatelet therapy
The efficacy and safety of low-molecular weight heparin 
(LMWH) or unfractionated heparin (UFH) use has not yet 
been proven in pediatric patients, except for some case 
reports demonstrating safety in preventing thrombotic 
events after ischemic stroke.81
The anticoagulant therapy, either in the acute phase of 
stroke or for the chronic management, is one of the major 
issues described in the 2008 guidelines in Chest82 and 
the American Heart Association (AHA).7 In AIS, the Chest 
guidelines recommend use of UFH or LMWH or aspirin (1 
mg/kg/day) until cardioembolic and dissection subtypes of 
stroke are excluded. The AHA recommendation addresses 
use of UFH or LMWH up to 1 week until the cause is 
determinate.83
When it comes to cardiac diseases as causes of stroke, 
the Chest guidelines recommend use of LMWH for over 6 
weeks. Surgical repair of the cardiac disease is the main 
step according to the AHA.
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As a secondary prevention, use of aspirin (1-5 mg/
kg/day) for over 2 years, once excluded dissection and 
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